Related Experiment Video

Updated: Feb 15, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K

Postdiagnosis aspirin use and overall survival in patients with melanoma

Saleh Rachidi1, Kristin Wallace2, Hong Li2

  • 1Department of Dermatology, Johns Hopkins Medicine, Baltimore, Maryland.

Journal of the American Academy of Dermatology
|January 11, 2018
PubMed
Abstract

Insights

Aspirin use may improve survival for melanoma patients, particularly in later stages. Further clinical trials are recommended to confirm aspirin's therapeutic potential in melanoma treatment.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Tumor-derived prostaglandins and platelets are known to advance melanoma and facilitate immune evasion in mice.
  • Understanding factors influencing melanoma progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the association between aspirin use and patient survival in melanoma.
  • To determine if aspirin confers a survival benefit in melanoma patients.

Main Methods:

  • A retrospective cohort study was conducted involving 1522 melanoma patients diagnosed between 2000 and 2014.
  • Patient data were analyzed for overall survival, considering factors like age, sex, and cancer stage.

Main Results:

  • Aspirin use was linked to longer overall survival in melanoma patients (HR, 0.58; 95% CI, 0.45-0.75).
  • This survival advantage was significant for stages II and III melanoma but not for in situ, stage I, or stage IV.
  • Patients using aspirin before diagnosis were less likely to have advanced-stage melanoma (III or IV).

Conclusions:

  • Aspirin may offer a survival advantage for patients with melanoma.
  • Further clinical trials are warranted to explore the therapeutic role of aspirin in melanoma management.
Keywords:
aspirinmelanomaplateletsstagesurvivaltreatment

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.6K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.3K

Related Concept Videos

Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
751
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
439
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
844
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
619
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
643
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
438